ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,740.52
-0.08%
Dow Jones
42,352.60
0.42%
US Dollar vs MXN
19.71266
0.46%
Brent Oil
71.765
1.15%
Bitcoin
65,780.38
0.91%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. PAVmed Inc (PAVM)

  7. PAVmed Inc (PAVM) Noticias

PAVM

PAVmed (PAVM)

PAVmed Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PAVM
FechaHoraFuenteTítuloSímboloCompañía
24/09/202407:01PR Newswire (US)American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer TestNASDAQ:PAVMPAVmed Inc
16/09/202415:30PR Newswire (US)PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing RequirementsNASDAQ:PAVMPAVmed Inc
10/09/202406:56PR Newswire (US)Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World CongressNASDAQ:PAVMPAVmed Inc
03/09/202406:51PR Newswire (US)Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile HealthNASDAQ:PAVMPAVmed Inc
20/08/202407:16PR Newswire (US)Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and CancerNASDAQ:PAVMPAVmed Inc
13/08/202407:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMPAVmed Inc
13/08/202407:16PR Newswire (US)The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal CancerNASDAQ:PAVMPAVmed Inc
13/08/202407:01PR Newswire (US)PAVmed Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
12/08/202415:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PAVMPAVmed Inc
12/08/202407:07PR Newswire (US)Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
08/08/202407:31PR Newswire (US)Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard® #CheckYourFoodTube Precancer Testing EventNASDAQ:PAVMPAVmed Inc
06/08/202407:15PR Newswire (US)Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
05/08/202407:15PR Newswire (US)Lucid Diagnostics to Participate in Upcoming Investor ConferencesNASDAQ:PAVMPAVmed Inc
30/07/202407:15PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:PAVMPAVmed Inc
29/07/202407:15PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024NASDAQ:PAVMPAVmed Inc
23/07/202407:01PR Newswire (US)Lucid Diagnostics Announces Record Quarterly EsoGuard® Test VolumeNASDAQ:PAVMPAVmed Inc
11/07/202407:31PR Newswire (US)Lucid Diagnostics Launches New Corporate WebsiteNASDAQ:PAVMPAVmed Inc
02/07/202406:55PR Newswire (US)Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:PAVMPAVmed Inc
13/06/202406:58PR Newswire (US)PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
12/06/202407:05PR Newswire (US)4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
13/05/202419:43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
13/05/202407:00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
09/05/202406:49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:PAVMPAVmed Inc
07/05/202406:39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:PAVMPAVmed Inc
03/05/202407:35PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024NASDAQ:PAVMPAVmed Inc
02/05/202407:35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:PAVMPAVmed Inc
02/05/202406:49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
30/04/202406:35PR Newswire (US)PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
29/04/202407:47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:PAVMPAVmed Inc
08/04/202407:30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PAVMPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVM

Su Consulta Reciente

NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
COIN
DOGEUSD
Dogecoin
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
COIN
ADAUSD
Cardano
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados